Kyverna Therapeutics, Inc. KYTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $124.09M+28.4% | $96.62M+179% | $34.65M— | ||
| $155.16M-18.1% | $189.36M+727% | $22.9M— | ||
| $551K-0.2% | $552K-2.3% | $565K— | ||
| $15.14M-9.3% | $16.69M— | —— | ||
| $282.95M-2.6% | $290.6M+379% | $60.66M— | ||
| $1.55M-53.8% | $3.35M+43.9% | $2.33M— | ||
| $3.57M-44.8% | $6.47M-0.4% | $6.49M— | ||
| $4.9M+72.9% | $2.84M-15.5% | $3.36M— | ||
| $293.83M-3.6% | $304.65M+305% | $75.2M— | ||
| $26.71M-0.6% | $26.87M+392% | $5.46M— | ||
| $9.99M+105% | $4.88M+73.6% | $2.81M— | ||
| $307K-60.6% | $779K-18.5% | $956K— | ||
| $3.66M+15.8% | $3.16M+60.9% | $1.96M— | ||
| $307K-60.6% | $779K-18.5% | $956K— | ||
| $36.49M+8.1% | $33.76M+70.0% | $19.86M— | ||
| $320K-92.3% | $4.16M-20.6% | $5.24M— | ||
| $307K-66.7% | $921K— | —— | ||
| $3.98M-45.6% | $7.32M— | —— | ||
| $0-100% | $142K-84.6% | $921K— | ||
| $61.55M+61.7% | $38.06M+46.3% | $26.02M— | ||
| $0— | $0— | —— | ||
| $1K— | $0— | —— | ||
| $657.01M+24.0% | $530M+11,318% | $4.64M— | ||
| -$424.83M-61.2% | -$263.52M-93.7% | -$136.04M— | ||
| $97K-7.6% | $105K+2,525% | $4K— | ||
| $232.28M-12.9% | $266.59M+2,129% | -$13.14M+82.2% | ||
| $293.83M-3.6% | $304.65M+305% | $75.2M— | ||
| $155.16M-18.1% | $189.36M+727% | $22.9M— | ||
| $4.9M+72.9% | $2.84M-15.5% | $3.36M— | ||
| $3.57M-44.8% | $6.47M-0.4% | $6.49M— | ||
| $3.57M-44.8% | $6.47M-0.4% | $6.49M— | ||
| $4.9M+72.9% | $2.84M-15.5% | $3.36M— | ||
| $3.57M-44.8% | $6.47M-0.4% | $6.49M— | ||
| $4.9M+72.9% | $2.84M-15.5% | $3.36M— | ||
| $3.75M-40.0% | $6.25M0.0% | $6.25M— | ||
| $13.47M-4.2% | $14.06M+300% | $3.52M— | ||
| $24.74M— | $0— | —— | ||
| $4.6M-49.1% | $9.02M-0.6% | $9.08M— | ||
| $657.01M+24.0% | $530M+11,318% | $4.64M— | ||
| $1K— | $0— | —— | ||
| $0— | $0— | —— | ||
| $307K-60.6% | $779K-18.5% | $956K— | ||
| $305K-63.7% | $841K-53.0% | $1.79M— | ||
| $24.74M— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kyverna Therapeutics, Inc.'s total assets?
- Kyverna Therapeutics, Inc. (KYTX) holds $257.0M in total assets, down 1.4% year over year.
- How much debt does Kyverna Therapeutics, Inc. have?
- Kyverna Therapeutics, Inc. carries $9.2M in total debt against $195.6M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Kyverna Therapeutics, Inc. have?
- Kyverna Therapeutics, Inc. holds $32.2M in cash and equivalents.
- Can Kyverna Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.15 — current assets exceed current liabilities.
- Where does Kyverna Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Kyverna Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.